Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis.

Elizabeth Lee CarpenterSpencer G Van DecarAlexandra M AdamsAnne E O'SheaPatrick M McCarthyRobert Connor ChickGuy Travis CliftonTimothy J VreelandFranklin A ValderaAnkur TiwariDiane HalePhillip Kemp BohanAnnelies HickersonTodd SmolinskyKatryna ThomasJessica CindassJohn HyngstromAdam C BergerJames JakubJeffrey J SussmanMontaser F ShaheenXianzhong YuThomas E WagnerMark FariesGeorge E Peoples

Published in: Journal for immunotherapy of cancer (2023)

NCT02301611.

Keyphrases

double blind
phase iii
placebo controlled

phase ii
clinical trial

open label
study protocol

lymph node
randomized controlled trial